Business Description
Prostalund AB
ISIN : SE0002372318
Description
Prostalund AB is a medical technology company engaged in development of products and treatments in urology.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.73 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.32 | |||||
| Beneish M-Score | -2.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.1 | |||||
| 3-Year EBITDA Growth Rate | 1.7 | |||||
| 3-Year EPS without NRI Growth Rate | 1.7 | |||||
| 3-Year FCF Growth Rate | -7.9 | |||||
| 3-Year Book Growth Rate | 7.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.61 | |||||
| 9-Day RSI | 46.83 | |||||
| 14-Day RSI | 47.75 | |||||
| 6-1 Month Momentum % | -0.98 | |||||
| 12-1 Month Momentum % | -84.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.97 | |||||
| Quick Ratio | 2.6 | |||||
| Cash Ratio | 1.97 | |||||
| Days Inventory | 1117.73 | |||||
| Days Sales Outstanding | 46.51 | |||||
| Days Payable | 393.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -21.1 | |||||
| Shareholder Yield % | -2.12 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.29 | |||||
| Operating Margin % | -121.13 | |||||
| Net Margin % | -122.04 | |||||
| FCF Margin % | -179.86 | |||||
| ROE % | -37.52 | |||||
| ROA % | -31.96 | |||||
| ROIC % | -44 | |||||
| ROC (Joel Greenblatt) % | -177.29 | |||||
| ROCE % | -36.52 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.31 | |||||
| PB Ratio | 0.51 | |||||
| EV-to-EBIT | -1.06 | |||||
| EV-to-EBITDA | -1.06 | |||||
| EV-to-Revenue | 1.29 | |||||
| EV-to-FCF | -0.63 | |||||
| Earnings Yield (Greenblatt) % | -94.81 | |||||
| FCF Yield % | -92.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prostalund AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.45 | ||
| EPS (TTM) (€) | -0.02 | ||
| Beta | 29.99 | ||
| Volatility % | 6180.18 | ||
| 14-Day RSI | 47.75 | ||
| 14-Day ATR (€) | 0.006685 | ||
| 20-Day SMA (€) | 0.00448 | ||
| 12-1 Month Momentum % | -84.64 | ||
| 52-Week Range (€) | 0.0002 - 0.132 | ||
| Shares Outstanding (Mil) | 123.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prostalund AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prostalund AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Prostalund AB Frequently Asked Questions
What is Prostalund AB(FRA:7PL)'s stock price today?
The current price of FRA:7PL is €0.00. The 52 week high of FRA:7PL is €0.13 and 52 week low is €0.00.
When is next earnings date of Prostalund AB(FRA:7PL)?
The next earnings date of Prostalund AB(FRA:7PL) is 2025-02-20.
Does Prostalund AB(FRA:7PL) pay dividends? If so, how much?
Prostalund AB(FRA:7PL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers